Anja Harder

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Pluripotent Stem Cells

Subarachnoid Hemorrhage

Peripheral Nerve

Top Venues

BMC research notes

This page only lists publications with an associated author ORCID identifier.

Publications

Miriam Renz, Pascal Siegert, Katja Mohnke, Robert Ruemmler, Katrin B M Frauenknecht, Clemens Sommer, Anja Harder
Precise Definition of Porcine Hippocampal Cornu Ammonis 2: High Histoarchitectural Similarity to Humans but Unequal Sensitivity to Hypoxia. Biomedicines 12 (8) (2024)
Miriam Renz, Pascal Siegert, Katja Mohnke, Robert Ruemmler, Katrin B M Frauenknecht, Clemens Sommer, Anja Harder
Precise Definition of Porcine Hippocampal Cornu Ammonis 2: High Histoarchitectural Similarity to Humans but Unequal Sensitivity to Hypoxia. Biomedicines 12 (8) (2024)
Paola Schildhauer, Philipp Selke, Martin Sebastian Staege, Anja Harder, Christian Scheller, Christian Strauss, Rüdiger Horstkorte, Maximilian Scheer, Sandra Leisz
Glycation Interferes with the Expression of Sialyltransferases and Leads to Increased Polysialylation in Glioblastoma Cells. Cells 12 (23) (2023)
Maximilian Scheer, Sandra Leisz, Eberhard Sorge, Olha Storozhuk, Julian Prell, Ivy A W Ho, Anja Harder
Neurofibromatosis Type 1 Gene Alterations Define Specific Features of a Subset of Glioblastomas. International journal of molecular sciences 23 (1) (2021)
Christian Linke, Markus Wösle, Anja Harder
Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. BMC cancer 20 (1) (2020)
Susan Fischer-Huchzermeyer, Levan Chikobava, Verena Stahn, Monique Zangarini, Philip Berry, Gareth J Veal, Volker Senner, Victor F Mautner, Anja Harder
Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts. BMC research notes 11 (1) (2018)
Susan Fischer-Huchzermeyer, Anna Dombrowski, Gordon Wilke, Verena Stahn, Anna Streubel, Victor Felix Mautner, Anja Harder
MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro. PloS one 12 (11) (2017)